Subject: BioCorRx Inc. Reports First Quarter 2015 Financial Results

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
BioCorRx Inc. Reports First Quarter 2015 Financial Results
Hot Stock to WatchHot Stock to Watch

Company: BioCorRx Inc. (OTCQB: BICX)


Price: 0.07

Change (%): + 0.002 (2.94)

Volume: 1,300
BICX Chart

BioCorRx Inc. Reports First Quarter 2015 Financial Results

Los Angeles, May 20, 2015 (GLOBE NEWSWIRE) - BioCorRx, Inc. (BICX), developer of the Start Fresh Program® used for the treatment of alcohol and opioid dependence, announces its first quarter 2015 Financial Results.

Revenues in the first quarter were $275,465, up over 110% from the first quarter of 2014.

Highlights for the quarter ending March 31, 2015:

  • Total revenue was $275,465, compared to total revenue of $130,829 for the first quarter of 2014.
  • Total operating expenses were $283,134, compared to operating expenses of $522,555 for first quarter 2014 which reflect a decrease of 46%.
“We continue to see a great drive in our business model with increased revenues. Last year ended with what we believe was a fantastic year for the Company highlighted by many key accomplishments including elimination of convertible debt, expanding our core market and being cash flow positive. We believe we are now poised for a solid 2015, building upon strong continued interest and support from physicians and clinics offering the Start Fresh Program. Our branding efforts continue to give the Company much broader visibility in the addiction community,” said Lourdes Felix, CFO of BioCorRx Inc.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks